- Previous Rank709
- Revenues ($M)3,647
- Revenue Percent Change16.7%
- Profits ($M)165
- Profits Percent Change-
- Market Value (as of March 31, 2015)-
Looking for leads, investment insights, or competitive intelligence?Buy Now
Company Info
| CEO | Brenton L. Saunders |
| Industry | Pharmaceuticals |
| Sector | Health Care |
| HQ Location | New York, NY |
| Website | http://www.actavis.com |
| Years on List | - |
Key Financials (last fiscal year)
| $ millions | % change | |
|---|---|---|
| Revenues ($M) | 3,647 | 16.7% |
| Profits ($M) | 165 | - |
| Total Stockholder Equity | 6,166 | - |
| Employees | 6,200 | - |
| Market Value (as of March 31, 2015) | - | - |
Profit Ratios
| Profit as % of Revenues | 4.5% |
| Profits as % of Assets | 1.4% |
| Profits as % of Stockholder Equity | 2.7% |
Earnings Per Share (last fiscal year)
| Earnings Per Share ($) | 0.61 |
| EPS % Change (from 2013) | - |
| EPS % Change (5 year annual rate) | -24.7% |
| EPS % Change (10 year annual rate) | -11% |
Total Return
| Total Return to Investors (2014) | - |
| Total Return to Investors (5 year, annualized) | - |
| Total Return to Investors (10 year, annualized) | - |
